To compare the performance of convex probe endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) with conventional endobronchial biopsy (EBB) or transbronchial lung biopsy (TBLB) in patients with mediastinal, and coexisting endobronchial or peripheral lesions.
Introduction
The planning of a bronchoscopic diagnostic procedure for a lesion in the lung begins from a computed tomography (CT). If the CT shows a peripheral mass beyond the visible segmental bronchi with a bronchus sign, the conventional bronchoscopic technique associated with the highest yield is transbronchial lung biopsy (TBLB). [1] [2] [3] [4] [5] [6] If the CT raises suspicion of an exophytic endobronchial lesion, the bronchoscopic technique associated with the highest yield is endobronchial biopsy (EBB). [7] [8] [9] If the CT scan shows mediastinal lesion, the preferred modality is blind or convex probe endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA). [10] [11] [12] [13] [14] [15] The decision making is easy in patients with isolated mediastinal, peripheral, or endobronchial lesion. However, some patients present with concomitant "mediastinal lesion" amenable to convex probe EBUS-TBNA, "endobronchial lesion" amenable to bronchial biopsy, and/or "peripheral lesion" amenable to TBLB in the same patient. [16] Although combining various techniques such as bronchial washing (BW), brushing, and biopsy increases the diagnostic yield, whether all the sites should be sampled in these patients employing all above-stated techniques or one site with one technique is adequate remains an unanswered question. [17] [18] [19] [20] [21] It is conceivable that sampling one site with single technique would be more effective in terms of cost, labor, and time. Furthermore, any preferred technique would need to have good safety profile, and high diagnostic yield.
The diagnostic yield and safety profile of convex probe EBUS-TBNA for mediastinal lesion is reportedly excellent. [11, 12] It is known that needle techniques provide a higher diagnostic yield than bronchoalveolar lavage (BAL), brush, or forceps biopsy due to their potential to bypass surface and sample viable tumor or lymph-nodes beneath the trachea and bronchi. [22, 23] EBUS-TBNA bypasses the surface, and samples from beneath the trachea and bronchi; this obviates the biopsy of the airway or peripheral lesion thus preventing flooding of the airways with blood as is associated with bronchial or TBLB. Correspondingly, the performance of convex probe EBUS-TBNA has been compared with other bronchoscopic techniques, and its superiority established in diseases like sarcoidosis. [24] [25] [26] [27] [28] However, literature on such comparison among patients with lung cancer or other benign diseases is sparse.
We hypothesized that the convex probe EBUS-TBNA as the sole and 1st line bronchoscopic technique in patients with mediastinal and coexisting peripheral or bronchial lesion is equivalent to conventional TBLB and EBB, respectively, in terms of yield, and safer in terms of complications. This study compares the performance of convex probe EBUS-TBNA with TBLB or EBB done sequentially in the same sitting, in patients with mediastinal and coexistent peripheral, or endobronchial lesions.
Methods
Retrospective review of records of patients who underwent EBUS-TBNA in 2014 and had mediastinal, and coexisting endobronchial or peripheral lesions were done (Fig. 1 ). Data were collected on demographics, CT findings, bronchoscopic findings, endobronchial ultrasound findings, type of diagnostic technique employed, and pathological result. Approval from institutional review board (DSRB) was obtained.
Definition of CT and bronchoscopic abnormalities
The size of mediastinal lesion was considered 1 cm when the diameter of the mediastinal lymph node or mass was 1 cm in short axis, and it was considered >1 cm when the diameter of the mediastinal lymph node or mass was >1 cm in short axis. Endobronchial exophytic lesion was defined as a lesion (tumorous growth) protruding into the lumen of the airways and visible on bronchoscopy. Endobronchial "mucosal hyperemia" was defined as an abnormal appearance of the mucosa in the form of erythema or neovascularization limited to the surface of the airway without any protrusion/elevation above the surface of the airways. Peripheral parenchymal lesion with bronchus sign was defined based on CT findings as a lesion ≥3 cm in largest diameter in the outer 3rd of the hemithorax with the finding of a bronchus leading directly to or contained within the peripheral lung mass. Peripheral parenchymal lesion without bronchus sign was defined as a lesion ≥3 cm in largest diameter in the outer 3rd of the hemithorax without any bronchus leading directly into the peripheral lung mass (Fig. 2). 
Description of methodology of bronchoscopic techniques
All procedures were done by a single or 2 (including trainees) operators via the transoral route under local anesthesia (lignocaine) and moderate sedation (midazolam) in a unintubated state in the endoscopy center of a tertiary hospital.
Endobronchial biopsy
Tumors which were visibly protruding or polypoidal (exophytic) were biopsied using flexible biopsy forceps inserted through the working channel of the flexible bronchoscope. In case of tumors in difficult locations (e.g., lateral wall), the tip of the bronchoscope was flexed as far as possible so that opened forceps could be jammed against the surface of tumor. One or 2 biopsies were taken in each visible lesion. The biopsied material obtained by forceps was transferred to a bottle containing 10% formalin and sent for histopathological examination. [18] Postbiopsy bleeding was arrested by iced cold saline or adrenalin instillation.
Transbronchial lung biopsy
All transbronchial lung biopsies were done under fluoroscopy guidance. After the appropriate subsegmental bronchus was endoscopically selected, the forceps were advanced under fluoroscopic guidance and upon encountering resistance, the forceps were withdrawn 1 cm and opened and advanced again until resistance was met. Following this, the forceps were closed and withdrawn, while the bronchoscope was wedged in the biopsied segment/subsegment for 30 seconds. Two to 3 biopsies, or as permitted by the degree of the postbiopsy airway bleeding, were taken. Postprocedure chest roentgenograms were obtained within 2 or more hours. [29] 2.5. Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) EBUS-TBNA was performed by 2 trained operators using a curvilinear scanning ultrasound bronchoscope (BF UC260F-OL8, Olympus Ltd., Tokyo, Japan) connected to an ultrasound unit (EU-C60 Olympus Ltd., Tokyo, Japan). For paratracheal lesions, the scope was positioned endotracheally. For peribronchial lesions the scope was positioned in the respective bronchi in order to visualize the lung lesion. TBNA was performed using a 22-gauge needle (NA-2015X-4022, Olympus Ltd., Tokyo, Japan). Two aspirates were performed with 15 revolutions (moving needle back and forth in the lesion) per aspirate. The core tissue was expelled onto piece of paper for histological examination and the needle was flushed with saline onto glass slides for cytological examination. The aspirate was smeared onto glass slides, air dried, fixed immediately with 95% alcohol. Histological cores were fixed with 10% neutral buffered formalin. Rapid on-site cytological examination was not available. A postprocedure chest X-ray was routinely performed to exclude any procedure-related complications. [13] 
Data analysis
The diagnosis detection rate of various techniques was analyzed based on the radiological features of presence versus absence of The results were compared using a Wilcoxon 2-sample test or Fisher exact test. P values were 2 sided and considered indicative of a significant difference if less than 0.05.
Results
Seventy four patients undergoing diagnostic bronchoscopic procedure for mediastinal and coexistent endobronchial or peripheral lesions in 2014 were studied (Table 1 ). All patients underwent convex probe EBUS-TBNA and BAL/BWs. Additionally, 19 underwent EBB and 20 underwent TBLB. Median (range) age was 63 (33-82) years and 51 (68.9%) were males. Final diagnosis was malignancy in 57, benign disease in 9, and unknown in 8 ( Table 2 ). In the whole cohort, detection rate of EBUS-TBNA alone for the mediastinal lesion was similar to EBB via biopsy forceps alone for the endobronchial lesion, and TBLB via biopsy forceps alone for the peripheral lesion (≥3 cm in size). Detection rate of combined EBUS-TBNA plus EBB (89.4%) was superior to EBUS-TBNA alone (59.4%) in patients with mediastinal and coexisting endobronchial lesions (P = 0.01) (Fig. 3) . Detection rate of combined EBUS-TBNA and EBB plus TBLB (79.4%) was superior to EBUS-TBNA alone (59.4%) in those who underwent combined procedures (P = 0.03) ( Table 3) .
In subgroup analysis based on the radiological features of presence versus absence of bronchus sign, endobronchial features of mucosal hyperemia versus exophytic lesion, and size of the mediastinal lesion of 1 versus >1 cm, the detection rate of EBUS-TBNA alone for mediastinal lesion >1 cm in short axis, EBB alone for visible exophytic type of endobronchial lesion, and TBLB alone for peripheral lesion with bronchus sign was 71%, 75%, and 86%, respectively. In contrast, the detection rate of EBUS-TBNA for mediastinal lesion 1 cm in short axis, EBB for mucosal hyperemia type of endobronchial lesion, and TBLB for peripheral lesion without bronchus sign were 25%, 63%, and 38%, respectively. The addition of EBB and TBLB to EBUS-TBNA for mediastinal lesion 1 cm in short axis, addition of EBUS-TBNA to EBB for mucosal hyperemia type of endobronchial lesion, and addition of EBUS-TBNA to TBLB for peripheral lesion without bronchus sign improved the detection rate exponentially to 63%, 88%, and 62%, respectively (Table 4) .
In subgroup analysis based on the etiology of the lesion, in patients with malignant lesion, the detection rate of EBUS-TBNA alone for the mediastinal lesion (72%), EBB alone for the endobronchial lesion (63%), and TBLB alone for the peripheral lesion (57%), were similar without any statistical difference. Detection rate of combined EBUS-TBNA plus EBB (100%) was superior to EBUS-TBNA alone (72%) in cancer patients with mediastinal and coexisting endobronchial lesions (P = 0.01). In patients with benign disease, there was no difference in detection rate between EBUS-TBNA alone and other techniques-single or in combination.
With regards to complications, postprocedure bleeding was significantly more common in patients who underwent EBB and TBLB 8 (40%) as compared to those undergoing convex probe EBUS-TBNA 2 (2.7%), P = 0.0004.
Discussion
We illustrated that EBUS-TBNA is adequate, and safer single technique of choice in patients with mediastinal lesion of shortaxis diameter of >1 cm in size, and coexisting exophytic type of endobronchial lesion amenable to EBB, or peripheral lesion with bronchus sign amenable to TBLB. However, it requires combining with EBB or TBLB and vice versa to optimize yield when diameter of mediastinal lesion in short-axis is 1 cm in size, and coexisting endobronchial and peripheral lesions lacking exophytic nature, and bronchus sign, respectively. Detection rate of BAL/BW in all patients combined was 24.3%. In patients with mediastinal lesion and coexistent peripheral lesion with bronchus sign, it was 43%. This is consistent with the existing literature where the diagnostic yield of BAL has been reported as 19.3 in all types of lesions, and 30% with a peripheral lung lesion. [30, 31] The pooled sensitivity of BWs has been reported as 48% in patients with endobronchial lesions and 43% in patients with peripheral lesions. [19, 30, 31] TBLB in patients with peripheral lesions of more than 3 cm in diameter regardless of the bronchus sign showed the detection rate of 50%. Among those with the bronchus sign, the detection rate of TBLB was 86%, whereas it was 38% in those without bronchus sign. The average yield of TBLB reported in the literature is 57% with range from 17% to 77% in patients with peripheral cancers depending of the size of the lesion and the presence or absence of bronchus sign. [17] In patients with ≥2 cm lesion, the yield is 63%, slightly higher than our cohort. [32] In patients with bronchus sign, our findings are consistent with the reported yield of 60% to 82% versus 0% to 44% for those without bronchus sign. [3] [4] [5] [6] Detection rate of bronchial biopsy using forceps in patients with endobronchial lesion regardless of whether the lesion was a "hyperemia type of mucosal abnormality" or an "exophytic lesion" showed the detection rate of 57.8% in the whole group. Among the "mucosal hyperemia" type of abnormality and the exophytic lesion, EBB was more diagnostic in exophytic lesions compared with "mucosal hyperemia" type of abnormality only (75% vs 62.5%). These findings are in keeping with the existing literature reporting the yield of EBB as 74% overall, and 90% in those with exophytic lesion. [31] The reason for relatively lower yield in our cohort of patients with exophytic lesions could be due to less number of biopsy attempts to minimize risk of bleeding. The incidence of bleeding in patients undergoing EBB or TBLB was 40% in our cohort.
The detection rate of convex probe EBUS-TBNA regardless of the size of the lesion was 59.4% in the whole group. This diagnostic yield is less than what is reported in the literature. However, the detection rate was 71% in those with the mediastinal lesion of greater than 1 cm in size and 25% in those with the mediastinal lesion of less than 1 cm in size. The diagnostic yield of convex probe EBUS-TBNA has been reported as 86% to 94% in the literature. [11, 12, 33] The reasons for lower yield in our cohort could be the inclusion of patients with mediastinal lesions of 1 cm in diameter, and reduced number of passes in each lesion. We performed 2 passes per station or lesion due to suboptimal patient cooperation as we perform the procedures without endotracheal tube and monitored anesthesia care. In the absence of a protected airway and monitored anesthetic care, patients' cooperation was suboptimal. Care was taken during the procedures to avoid over sedation which may result in respiratory suppression and airway compromise. We postulate that diagnostic yield from EBUS-TBNA would be expected to be higher in centers where EBUS-TBNA is performed via the endotracheal route and where dedicated anaesthetic care is available.
Combining the bronchoscopic techniques has been shown to increase the yield. The overall yield by all, washing, brushing, and endobronchial biopsy was found to be 80% in patients with suspected lung cancer in 1 study and authors concluded that for maximal yield, bronchoscopists should perform all 3 techniques. [18] The benefit of combination was seen in our cohort too. The addition of EBUS-TBNA improved the detection rate of BAL/ Data presented in number (%). EBUS-TBNA = endobronchial ultrasound guided transbronchial needle aspiration. Table 2 Final diagnosis in 74 patients. Data presented in number (%).
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BW from 24.3% to 63.5% in the whole group. In case of TBLB, addition of EBUS-TBNA increased the overall yield from 50% to 70% in the whole group. In the case of EBB, the addition of EBUS-TBNA improved the detection rate from 57.8% to 89.4%. By combining techniques, the detection rate in the group that had lower yield such as "mucosal hyperemia" type of endobronchial Figure 3 . Analysis of diagnosis detection rate based on the bronchoscopic technique in the whole group. Table 3 Analysis of diagnosis detection rate based on the bronchoscopic technique. abnormality, "peripheral lesion lacking bronchus sign," and "small size mediastinal lesion" improved from 63% to 88%, 38% to 78%, and 25% to 63%, respectively, similar to their counterparts with exophytic lesion, bronchus sign, and large size mediastinal lesion. These findings imply that in patients with mediastinal, and coexisting parenchymal or endobronchial lesions, the decision regarding the single best bronchoscopic technique of choice should be based on the size of the mediastinal lesion, presence or absence of exophytic type of endobronchial lesion, and presence or absence of bronchus sign in case of peripheral lesion (Fig. 4) .
Our study has limitations. First, it is a single center retrospective study with small numbers. Second, using a single bronchoscopic technique in patients with lesions at multiple sites may carry the risk of missing a double pathology. Third, it is not applicable to centers that do not practice EBUS-TBNA.
In conclusion, endobronchial lesions that are exophytic in nature, peripheral parenchymal masses with the bronchus sign, and mediastinal lesion that are larger than 1 cm in diameter in short axis have an equally better detection rate (>70%) with EBB, TBLB, and convex probe EBUS-TBNA, respectively, as compared to 60% in endobronchial lesion with just a "mucosal Table 4 Analysis of diagnosis detection rate (N [%] ) based on characteristic features of the lesion and the procedures (EBUS-TBNA, BW, EBB, and TBLB) performed. Data presented in number (%).BW = bronchial washing, EBB = endobronchial lung biopsy, EBUS-TBNA = endobronchial ultrasound guided transbronchial needle aspiration, TBLB = transbronchial lung biopsy. hyperemia" type of abnormality, peripheral mass without the bronchus sign, and mediastinal lesions smaller than 1 cm in size. Hence, in patients with large mediastinal lesion, and either coexistent exophytic endobronchial lesion in the airways, or peripheral mass with the bronchus sign, any one of the 3 abovestated techniques may be adequate. However, since EBUS-TBNA is least associated with the complication of bleeding, it may be the most preferable single diagnostic procedure due to its yield, safety, and ability to provide nodal staging. On the other hand, in patients with small (1 cm) mediastinal lesion, and coexisting "nonexophytic" type of endobronchial lesion, or peripheral lesion without the bronchus sign, combining EBUS-TBNA with EBB or TBLB may be preferable to optimize the detection rate.
